Literature DB >> 16142759

Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.

David Saadoun1, Ivan Bieche, Thierry Maisonobe, Tarik Asselah, Ingrid Laurendeau, Jean Charles Piette, Michel Vidaud, Patrice Cacoub.   

Abstract

OBJECTIVE: To examine the expression profiles of a large number of genes within typical vasculitic nerve lesions in patients with mixed cryoglobulinemia (MC) vasculitis in order to better characterize the molecules involved in cellular tissue activation and trafficking.
METHODS: The quantitative expression of 19 genes coding for cytokines, chemokines, and their receptors in the nerve lesions of 9 patients with hepatitis C virus (HCV)-associated MC vasculitis, 7 with idiopathic polyarteritis nodosa (PAN) (rheumatic disease controls), and 8 patients with noninflammatory idiopathic neuropathy (noninflammatory neuropathy controls) was assessed using a real-time reverse transcriptase-polymerase chain reaction procedure.
RESULTS: Compared with the noninflammatory controls, HCV-MC vasculitis patients had a significantly higher expression of Th1 cytokines in vasculitic nerve lesions (mean +/- SEM fold increase 33.7 +/- 11.6 for interferon-gamma and 7.2 +/- 1.9 for tumor necrosis factor alpha), whereas Th2 cytokines were absent (interleukin-4 [IL-4], IL-5, and IL-13) or were not significantly different (IL-10). Chemokines involved in T cell and monocyte trafficking were also significantly up-regulated in the HCV-MC vasculitis patients (mean +/- SEM fold increase 27.4 +/- 8.3 for macrophage inflammatory protein 1alpha [MIP-1alpha], 19.9 +/- 5.7 for MIP-1beta, and 7.2 +/- 1.5 for CXCR3). Compared with patients with idiopathic PAN, there was a trend toward higher expression of MIP-1alpha and CXCR3 in HCV-MC vasculitis patients (mean +/- SEM fold increase 27.4 +/- 8.3 versus 5.3 +/- 3.4 for MIP-1alpha and 7.2 +/- 1.5 versus 2.5 +/- 0.9 for CXCR3).
CONCLUSION: This study is the first to demonstrate a role of cellular immunity and Th1 lymphocytes in the pathogenesis of HCV-MC vasculitic nerve lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142759     DOI: 10.1002/art.21270

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  19 in total

1.  Immunohistochemical detection of HCV in nerves and muscles of patients with HCV associated peripheral neuropathy and myositis.

Authors:  Layla K Younis; Farouk M Talaat; Ahmed H Deif; Mohamed F Borei; Seham M Abdel Reheim; Doa H El Salmawy
Journal:  Int J Health Sci (Qassim)       Date:  2007-07

Review 2.  Extrahepatic immune related manifestations in chronic hepatitis C virus infection.

Authors:  Maria Tampaki; John Koskinas
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 3.  Extrahepatic manifestations of chronic hepatitis C virus infection.

Authors:  Patrice Cacoub; Cloe Comarmond; Fanny Domont; Léa Savey; Anne C Desbois; David Saadoun
Journal:  Ther Adv Infect Dis       Date:  2016-02

4.  Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice.

Authors:  Ester Roffê; Ana Paula M P Marino; Joseph Weaver; Wuzhou Wan; Fernanda F de Araújo; Victoria Hoffman; Helton C Santiago; Philip M Murphy
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

Review 5.  The potential of cytokines as safety biomarkers for drug-induced liver injury.

Authors:  Hugh G Laverty; Daniel J Antoine; Craig Benson; Masautso Chaponda; Dominic Williams; B Kevin Park
Journal:  Eur J Clin Pharmacol       Date:  2010-08-06       Impact factor: 2.953

Review 6.  Chemokines in the immunopathogenesis of hepatitis C infection.

Authors:  Mathis Heydtmann; David H Adams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

Review 7.  Vasculitis: determinants of disease patterns.

Authors:  Gary S Hoffman; Leonard H Calabrese
Journal:  Nat Rev Rheumatol       Date:  2014-06-17       Impact factor: 20.543

Review 8.  The hepatitis C virus infection as a systemic disease.

Authors:  Anna Linda Zignego; Laura Gragnani; Carlo Giannini; Giacomo Laffi
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

Review 9.  Hepatitis C virus infection and mixed cryoglobulinemia.

Authors:  Gianfranco Lauletta; Sabino Russi; Vincenza Conteduca; Loredana Sansonno
Journal:  Clin Dev Immunol       Date:  2012-07-10

Review 10.  HCV and lymphoproliferation.

Authors:  Anna Linda Zignego; Carlo Giannini; Laura Gragnani
Journal:  Clin Dev Immunol       Date:  2012-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.